Non-Small Cell Lung Cancer p53 Hotspot Mutation Cell Panel (ATCC® TCP-2030)

Organism: Homo sapiens, human  / 

Organism Homo sapiens, human
Components BEAS-2B, ATCC CRL-9609
A549, ATCC CCL-185
NCI-H1299, ATCC CRL-5803
NCI-H596, ATCC HTB-178
NCI-H1770, ATCC CRL-5893
NCI-H1975, ATCC CRL-5908
Applications
Biological understanding of top genetic alterations across tumor types
Novel anti-cancer drug targeting
Reactivation of mutant p53
Studies related to p53 molecular mechanisms
Testing small molecules or biologics for cancer drug development
Type Strain no
Biosafety Level 2
Comments
The Non-Small Cell Lung Cancer p53 Hotspot Mutation Cell Panel (ATCC TCP-2030) is comprised of 6 select cell lines derived from the lung that have been sequenced and validated by ATCC. The panel includes both WT p53 cell lines as well as cultures with p53 hotspot mutations at codons 245, 248, or 273.
Product Format frozen
Storage Conditions LN vapor (less than -130°C) only